PSI PHARMACEUTICALS LTD
Significant control: Adam David George (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Psi Pharmaceuticals Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Psi Pharmaceuticals Ltd sell?
Registered activity: Manufacture of pharmaceutical preparations (SIC 21200). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
PSI PHARMACEUTICALS LTD is an active private limited company (company number 13775713) incorporated on 1 December 2021, registered in Calne. Its registered activity is manufacture of pharmaceutical preparations (SIC 21200). Latest micro accounts cover the period ending 31 December 2025, showing net assets of £605k, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets were unchanged on the prior period.
By net assets it sits in the top quarter of 307 comparable companies in the UK (median £1,000, upper quartile £146k).
Ownership and control
- Mr Adam David George
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 1 December 20214 yrs ago
- Next accounts due
- 30 September 2027in 340 days
- Confirmation statement due
- 15 December 2026in 51 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 21200
- Manufacture of pharmaceutical preparations
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £605k | — | — | £0 | — | — | 0 |
| 31 December 2024 | £606k | — | — | £0 | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £604,728 at 31 December 2025
- Incorporated two to five years agoIncorporated 1 December 2021
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 340 days
- Confirmation statement duein 51 days
- Accounts period endNet assets £605k · micro accounts
- Accounts period endNet assets £606k · micro accounts
- Incorporated
Similar companies in the UK
- CF PHARMA UK LTDPeterborough · inc. Oct 2021
- BIOSIRIUS LTDPoole · inc. Aug 2021
- CEUTICA LIMITEDSwindon · inc. Jul 2021
- COVGUARD LIMITEDCheltenham · inc. Jun 2021
- NEURONE LIMITEDCalne · inc. Jun 2021
- ABEL HEALTH SOLUTIONS LTDPlymouth · inc. Jun 2022
All companies incorporated on 1 December 2021 · in Dec 2021.
Reminders for PSI PHARMACEUTICALS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.